| Literature DB >> 31645796 |
Abstract
Despite lung cancer's prevalence and high burden of mortality, a useful screening program has taken a long time to develop. Now, most of the associated national organizations recommend low dose CT screening in the appropriate population. However, since the USPSTF guidelines were published, implementation has been slow. This article outlines the current evidence and provides additional resources to help physicians tailor a screening program for their patients. Copyright 2019 by the Missouri State Medical Association.Entities:
Mesh:
Year: 2019 PMID: 31645796 PMCID: PMC6797041
Source DB: PubMed Journal: Mo Med ISSN: 0026-6620